The nation of Zimbabwe has turned down a significant American healthcare agreement valued at $367m (£272m) spanning five years due to Washington's demand for sensitive information.
The decision became public after a internal memorandum dated December was disclosed, which showed President Emmerson Mnangagwa felt the deal was "lopsided".
An official spokesman has since stated that the United States was requesting health data for scientific study and commercial gain but was unwilling to guarantee the benefits from future treatments.
"We will now turn to the challenging and unfortunate task of ending our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had furnished over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has called for more negotiations to find a deal suitable to both sides so the nation's critical HIV programme can be sustained.
Broader Context
This rejection comes after a comparable case in neighbouring Kenya, where a court halted a similar health funding agreement after concerns were filed about the safety of citizens' health data.
Since resuming office recently, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
USAID had administered assistance for the US government, but Trump stated its spending was "wasteful" and his administration was pursuing direct bilateral deals to enhance transparency and accountability.
Based on statements, Sixteen nations in Africa have so far agreed to these new health pacts, representing over $18.3bn in committed funds.
Details of the Rejected Agreement
The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this cooperation might have yielded extraordinary benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving HIV treatment via American-funded initiatives," Tremont added.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"The proposal required Zimbabwe to provide its biological resources and data indefinitely, with no equivalent promise of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that shared data," Mangwana explained.
"Put simply, our country would provide the basic resources for scientific discovery with no assurance that the resulting innovations would be accessible to our citizens if a future health crisis emerge."
National Interest and Global Health
Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of bilateral deals were disrupting structures previously established via the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework designed to deal with potential pandemics.
"This framework is intended to guarantee that when a country provides its data, the resulting advantages – such as vaccines and treatments – are shared equitably, not commercialised solely by those with the resources to develop them."
The government's concerns over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We welcome further dialogue with our US partners on how future collaboration might be designed in a manner that respects the independence and dignity of each country."
Health Experts Reaction
Medical experts said it recognised the official position, but suggested that negotiations must proceed given that much of the nation's Aids initiatives relied on foreign aid.
"Where technical issues arise, such as those relating to information security or implementation frameworks, these can often be resolved through technical clarification and mutually agreed protections," it commented.
This impasse emphasises the complex tensions between accepting crucial foreign assistance and safeguarding local interests in an ever more interconnected world.